Art. 14b Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…

In forcesince 5 Jun 2013cited 1×
1.

The marketing authorisation holder shall notify the Agency forthwith of any action the holder takes to suspend the marketing of a medicinal product, to withdraw a medicinal product from the market, to request the withdrawal of a marketing authorisation or not to apply for the renewal of a marketing authorisation, together with the reasons for such action. The marketing authorisation holder shall in particular declare if such action is based on any of the grounds set out in Article 116 or Article 117(1) of Directive 2001/83/EC.

2.

The marketing authorisation holder shall also make the notification pursuant to paragraph 1 of this Article if the action is taken in a third country and such action is based on any of the grounds set out in Article 116 or Article 117(1) of Directive 2001/83/EC.

3.

In the cases referred to in paragraphs 1 and 2, the Agency shall forward the information to the competent authorities of the Member States without undue delay.

  • The Human Medicines (Amendment) (No. 2) Regulations 20134Law

    … for “market).” substitute “market); or”. (4) After sub-paragraph (b) add the following sub-paragraph— (c) Article 14b of Regulation (EC) No 726/2004 (requirement to notify suspending of marketing of the product etc).